- Home
- HPS vs CLPT Comparison
HPS vs CLPT Comparison
Compare HPS & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPS
- CLPT
- Stock Information
- Founded
- HPS 2003
- CLPT 1998
- Country
- HPS United States
- CLPT United States
- Employees
- HPS N/A
- CLPT N/A
- Industry
- HPS Investment Managers
- CLPT Medical/Dental Instruments
- Sector
- HPS Finance
- CLPT Health Care
- Exchange
- HPS Nasdaq
- CLPT Nasdaq
- Market Cap
- HPS 480.4M
- CLPT 494.6M
- IPO Year
- HPS N/A
- CLPT N/A
- Fundamental
- Price
- HPS $14.93
- CLPT $14.23
- Analyst Decision
- HPS
- CLPT Strong Buy
- Analyst Count
- HPS 0
- CLPT 3
- Target Price
- HPS N/A
- CLPT $27.67
- AVG Volume (30 Days)
- HPS 58.4K
- CLPT 1.0M
- Earning Date
- HPS 01-01-0001
- CLPT 11-06-2025
- Dividend Yield
- HPS 8.62%
- CLPT N/A
- EPS Growth
- HPS N/A
- CLPT N/A
- EPS
- HPS N/A
- CLPT N/A
- Revenue
- HPS N/A
- CLPT $34,332,000.00
- Revenue This Year
- HPS N/A
- CLPT $22.34
- Revenue Next Year
- HPS N/A
- CLPT $25.50
- P/E Ratio
- HPS N/A
- CLPT N/A
- Revenue Growth
- HPS N/A
- CLPT 12.83
- 52 Week Low
- HPS $11.79
- CLPT $9.76
- 52 Week High
- HPS $15.40
- CLPT $30.10
- Technical
- Relative Strength Index (RSI)
- HPS 34.09
- CLPT 35.24
- Support Level
- HPS $14.68
- CLPT $13.33
- Resistance Level
- HPS $15.00
- CLPT $14.63
- Average True Range (ATR)
- HPS 0.17
- CLPT 1.19
- MACD
- HPS -0.07
- CLPT -0.36
- Stochastic Oscillator
- HPS 11.63
- CLPT 17.66
About HPS John Hancock Preferred Income Fund III Preferred Income Fund III
John Hancock Preferred Income Fund III is a closed-end, diversified management investment company. Its investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve the objectives by investing a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. The portfolio composition of the company consists of the U.S. preferred securities, foreign preferred securities, common stocks, corporate bonds, and the short-term investments.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.